tiprankstipranks
Climb Bio (CLYM)
NASDAQ:CLYM
US Market

Climb Bio (CLYM) Financial Statements

Compare
56 Followers

Climb Bio Financial Overview

Climb Bio's market cap is currently $98.93M. The company's EPS TTM is $-2.134; its P/E ratio is ―; Climb Bio is scheduled to report earnings on May 19, 2025, and the estimated EPS forecast is $-0.15. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue
Gross Profit-----
Operating Income$ -40.27M$ -45.13M$ -35.67M$ -20.93M$ -7.45M
EBITDA$ -35.12M$ -45.24M$ -47.23M$ -20.93M$ -7.45M
Net Income$ -35.12M$ -45.24M$ -47.48M$ -20.67M$ -6.55M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 110.47M$ 134.99M$ 173.24M$ 24.63M$ 21.39M
Total Debt$ 349.00K$ 480.00K$ 0.00$ 0.00$ 0.00
Net Debt$ -106.45M$ -123.09M$ -136.48M$ -20.49M$ -21.22M
Total Liabilities$ 2.87M$ 6.28M$ 6.04M$ 3.06M$ 783.00K
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -20.60M$ -37.37M$ -36.07M$ -14.10M$ -5.01M
Operating Cash Flow$ -20.60M$ -37.37M$ -36.07M$ -14.10M$ -5.01M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Climb Bio Earnings and Revenue History

Climb Bio Debt to Assets

Climb Bio Cash Flow

Climb Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis